| 000 | 01025 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513185332.0 | ||
| 264 | 0 | _c19990902 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(99)80011-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, Z M | |
| 245 | 0 | 0 |
_aModeling economic evaluations of pharmaceuticals: manipulation or valuable tool? _h[electronic resource] |
| 260 |
_bClinical therapeutics _cMay 1999 |
||
| 300 |
_a896-908; discussion 895 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEconomics, Pharmaceutical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aReproducibility of Results |
| 700 | 1 | _aMiller, D W | |
| 773 | 0 |
_tClinical therapeutics _gvol. 21 _gno. 5 _gp. 896-908; discussion 895 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(99)80011-3 _zAvailable from publisher's website |
| 999 |
_c10355661 _d10355661 |
||